Výsledky vyhledávání - "Kathryn A. Bylow"

Outcomes With Liver-Directed Therapy for Genitourinary Malignancies: Single-Institution Experience

Autor: Ruben Raychaudhuri, William B. Lea, Deepak Kilari, Kathryn A. Bylow, William S. Rilling, Michael Pierro, Nancy B. Davis

Publikováno v: Clinical Genitourinary Cancer. 19:87-91

Purpose Liver metastasis in genitourinary (GU) malignancies signifies a poor prognosis and has a negative effect on patient survival. Selected patients with metastatic GU malignancies have liver-dominant disease. Liver-directed therapies (LDT) with c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::614adfbc6ac26799c0d9e9034e0f6369
https://doi.org/10.1016/j.clgc.2020.07.010

Zobrazit plný text záznamu

The Role of Metastasectomy in Urothelial Carcinoma: Where Are We in 2020?

Autor: Deepak Kilari, Emily Lemke, Edward M. Messing, Scott Johnson, Elizabeth A. Guancial, Deepak M. Sahasrabudhe, Kathryn A. Bylow

Publikováno v: Clinical Genitourinary Cancer. 18:e478-e483

Systemic therapy is the mainstay of treatment for metastatic urothelial carcinoma (UC). Responses to first-line platinum-based therapy tend to be short-lived with potential toxicity. Despite the approval of checkpoint inhibitors, the long-term progno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d9176f9b2f4307c795e202de5d9f52
https://doi.org/10.1016/j.clgc.2020.01.003

Zobrazit plný text záznamu

Impact of pre-existing anemia and/or packed red blood cell transfusion prior to Radium-223 administration on oncologic outcomes

Autor: Michael Pierro, Ariel Ann Nelson, John Xie, Albert Jang, Kathryn A. Bylow, Pedro C. Barata, Colleen Anne Lawton, Deepak Kilari

Publikováno v: Journal of Clinical Oncology. 41:67-67

67 Background: Radium-223 (Ra-223), a targeted alpha-emitting radiopharmaceutical approved for the treatment of metastatic prostate cancer (mPC), can cause myelosuppression. In the ALSYMPCA trial 30% of patients developed cytopenias, including 13% wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0e3c7265ef95a7e8f086271f23c2b226
https://doi.org/10.1200/jco.2023.41.6_suppl.67

Zobrazit plný text záznamu

Immunohistochemical (IHC) subtypes of metastatic bladder cancer (mBC) using GATA3 and CK5/6

Autor: Ariel Ann Nelson, Mariel Molina Nunez, Kathryn A. Bylow, Aniko Szabo, Kenneth Iczkowski, Deepak Kilari

Publikováno v: Journal of Clinical Oncology. 41:557-557

557 Background: Genomic analyses have identified that bladder cancers can be divided into distinct molecular subtypes: luminal and basal. IHC markers GATA3 and CK5/6 have demonstrated >80% accuracy in assessing the luminal and basal subtypes of prima

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::50c87d891a8826dc049ee72549de840c
https://doi.org/10.1200/jco.2023.41.6_suppl.557

Zobrazit plný text záznamu

Abstract A034: Health-related quality of life among African American prostate cancer survivors enrolled in a lifestyle intervention program

Autor: Iwalola Awoyinka, Kathryn E. Flynn, Anjishnu Banerjee, Alexis Visotcky, Sophia Aboagye, Margaret Tovar, Deepak Kilari, Kathryn A. Bylow, Paula Papanek, Patricia M. Sheean, Melinda R. Stolley

Publikováno v: Cancer Epidemiology, Biomarkers & Prevention. 32:A034-A034

Background: Prostate cancer (PC) is the most diagnosed non-skin cancer among men in the United States, with African American (AA) men experiencing the highest incidence of all racial/ethnic groups. Screening and treatment advances for PC have resulte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::206a701ebdc8f9589e2b901e07cd573c
https://doi.org/10.1158/1538-7755.disp22-a034

Zobrazit plný text záznamu

A phase 2 study of cabozantinib in combination with atezolizumab as neoadjuvant treatment for muscle-invasive bladder cancer (HCRN GU18-343) ABATE study

Autor: Deepak Kilari, Aniko Szabo, Abhishek Tripathi, Asit K. Paul, Robert S. Alter, Kathryn A. Bylow, Ariel Ann Nelson, William A. Hall, Peter Langenstroer, Kenneth Jacobsohn, Brian I. Rini, Peter J. Van Veldhuizen, Scott Johnson, Nancy B. Davis, Chunkit Fung, Matthew I. Milowsky

Publikováno v: Journal of Clinical Oncology. 40:TPS4618-TPS4618

TPS4618 Background: ABACUS and PURE-01 trials demonstrated the activity of single agent atezolizumab and pembrolizumab respectively as neoadjuvant therapy for muscle invasive bladder carcinoma (MIBC). However, downstaging to non-muscle invasive disea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::df34831e343ed606132a8e8a47ac3af5
https://doi.org/10.1200/jco.2022.40.16_suppl.tps4618

Zobrazit plný text záznamu

A single-arm, open-label, phase 2 study evaluating pacritinib for patients with biochemical recurrence after definitive treatment for prostate cancer: Blast study

Autor: Deepak Kilari, Aniko Szabo, William A. Hall, Ariel Ann Nelson, Scott Johnson, Thomas A. Giever, John Burfeind, Parag Tolat, Kathryn A. Bylow, Kenneth Iczkowski, Yunguang Sun, Hallgeir Rui, James P. Thomas, Marja Nevalainen

Publikováno v: Journal of Clinical Oncology. 40:TPS220-TPS220

TPS220 Background: Androgen deprivation therapy (ADT) achieved with gonadotropin releasing hormone (GnRH) agonist or antagonist is considered the standard of care for men with prostate cancer (PC) who develop biochemical recurrence (BCR) after defini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2da45ad11de7e233fb573edcadf5aeec
https://doi.org/10.1200/jco.2022.40.6_suppl.tps220

Zobrazit plný text záznamu

The relationship between anxiety about prostate cancer among patients with biochemical cancer recurrence and the use of complementary and alternative medicines, diet, and exercise

Autor: Joshua Hemmerich, Walter M. Stadler, Kathryn A. Bylow, Richard T. Lee, Supriya G. Mohile, Nancy Kwon, William Dale

Publikováno v: Family Medicine and Community Health, Vol 5, Iss 2, Pp 139-148 (2017)

Objective We aimed to explore associations between anxiety and specific health behaviors such as complementary and alternative medicine (CAM), diet, and exercise among prostate cancer patients. Methods PCa patients enrolled in a prospective cohort st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97db9757340b5ed7fb8c1542edcd3907
http://www.ingentaconnect.com/content/cscript/fmch/2017/00000005/00000002/art00006

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání